Peter Cicala

Peter Cicala

Vice President of Intellectual Property, Chief Patent Counsel, Celgene Corporation

Mr. Peter Cicala is the Chief Patent Counsel and Vice President of Intellectual Property at Celgene Corporation. His legal practice focuses on all aspects of pharmaceutical and biotechnology intellectual property law. He has extensive experience in patent litigation, prosecution, product lifecycle management, R&D collaborations and joint ventures in the pharma/biotech industry.  Mr. Cicala has particular expertise with Hatch-Waxman Paragraph IV litigation as well as substantial experience with patent and regulatory litigation in Europe. Mr. Cicala has regularly participated in due diligence investigations, patent, trademark and copyright licensing, as well as M&A transactions and patent litigation settlements. Additionally, Mr. Cicala has over 10 years of experience as a medicinal chemist and has worked in drug development programs for several major pharmaceutical companies and universities.



Administrative "Death Squads" for Patents? Assessing the New Administrative Procedures for Challenging Patents
This event has concluded.